• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

既往有经皮冠状动脉介入治疗病史的患者,在再狭窄早期阶段之后新发冠状动脉疾病的相关因素。

Contributors to newly developed coronary artery disease in patients with a previous history of percutaneous coronary intervention beyond the early phase of restenosis.

作者信息

Endo Akihiro, Yoshida Yasuyuki, Kageshima Kenji, Sato Hirotomo, Suga Toshimitsu, Nasu Hiroshi, Takahashi Nobuyuki, Tanabe Kazuaki

机构信息

Division of Cardiology, Shimane University Faculty of Medicine, Japan.

出版信息

Intern Med. 2014;53(8):819-28. doi: 10.2169/internalmedicine.53.1438. Epub 2014 Apr 15.

DOI:10.2169/internalmedicine.53.1438
PMID:24739601
Abstract

OBJECTIVE

The low-density lipoprotein cholesterol (LDL-C)/high-density lipoprotein cholesterol (HDL-C) ratio is considered to be a sensitive marker of the risk of atherosclerotic cardiovascular disease; however, in patients with a previous history of percutaneous coronary intervention (PCI), there is little information regarding the predictive value of this parameter beyond the period of early restenosis. The aim of this study was to investigate contributing factors to newly developed coronary artery disease in patients with a previous history of PCI after stabilization.

METHODS

The clinical characteristics of 238 patients with a previous history of PCI who underwent coronary angiography following recurrent cardiac ischemia beyond the period of early restenosis were examined.

RESULTS

Overall, 64% of the patients underwent late revascularization, while 31% and 50% underwent late target lesion revascularization and new lesion revascularization, respectively. A multivariate analysis identified the LDL-C/HDL-C ratio to be an independent contributor to late revascularization (hazard ratio (HR), 1.37; p<0.001). Similarly, the independent contributors to late target lesion revascularization and new lesion revascularization were the non-HDL-C level and LDL-C/HDL-C ratio, respectively. Based on the median value of the LDL-C/HDL-C ratio, the patients were classified into high and low LDL-C/HDL-C ratio groups. The log-rank test revealed a significantly higher incidence of late revascularization in the high-LDL-C/HDL-C ratio group than in the low-LDL-C/HDL-C ratio group among the patients with an LDL-C level of ≥ 100 mg/dL (p=0.011). However, the difference between the two groups was diminished among the patients with an LDL-C level of <100 mg/dL (p=0.047), and only diabetes mellitus (HR, 2.239; p=0.009) was found to be an independent contributor to late coronary revascularization in these patients.

CONCLUSION

The LDL-C/HDL-C ratio is an important contributor to the development of new coronary artery disease in patients with a previous history of PCI beyond the period of early restenosis, particularly among patients with an LDL-C level of ≥ 100 mg/dL.

摘要

目的

低密度脂蛋白胆固醇(LDL-C)/高密度脂蛋白胆固醇(HDL-C)比值被认为是动脉粥样硬化性心血管疾病风险的敏感标志物;然而,对于有经皮冠状动脉介入治疗(PCI)既往史的患者,关于该参数在早期再狭窄期之后的预测价值的信息很少。本研究的目的是调查PCI既往史患者在病情稳定后新发冠状动脉疾病的相关因素。

方法

对238例有PCI既往史且在早期再狭窄期之后因复发性心脏缺血接受冠状动脉造影的患者的临床特征进行了检查。

结果

总体而言,64%的患者接受了晚期血运重建,而分别有31%和50%的患者接受了晚期靶病变血运重建和新病变血运重建。多因素分析确定LDL-C/HDL-C比值是晚期血运重建的独立影响因素(风险比[HR],1.37;p<0.001)。同样,晚期靶病变血运重建和新病变血运重建的独立影响因素分别是非HDL-C水平和LDL-C/HDL-C比值。根据LDL-C/HDL-C比值的中位数,将患者分为LDL-C/HDL-C比值高组和低组。对数秩检验显示,在LDL-C水平≥100mg/dL的患者中,高LDL-C/HDL-C比值组的晚期血运重建发生率显著高于低LDL-C/HDL-C比值组(p=0.011)。然而,在LDL-C水平<100mg/dL的患者中,两组之间的差异减小(p=0.047),并且仅发现糖尿病(HR,2.239;p=0.009)是这些患者晚期冠状动脉血运重建的独立影响因素。

结论

LDL-C/HDL-C比值是有PCI既往史的患者在早期再狭窄期之后新发冠状动脉疾病的重要影响因素,尤其是在LDL-C水平≥100mg/dL的患者中。

相似文献

1
Contributors to newly developed coronary artery disease in patients with a previous history of percutaneous coronary intervention beyond the early phase of restenosis.既往有经皮冠状动脉介入治疗病史的患者,在再狭窄早期阶段之后新发冠状动脉疾病的相关因素。
Intern Med. 2014;53(8):819-28. doi: 10.2169/internalmedicine.53.1438. Epub 2014 Apr 15.
2
Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.评估 LDL-C/HDL-C 比值对经皮冠状动脉介入治疗和药物洗脱支架置入术后急性冠脉综合征患者一年临床结局的预测价值。
Lipids Health Dis. 2019 Feb 2;18(1):40. doi: 10.1186/s12944-019-0979-6.
3
Sex difference between target levels of cholesterol-related parameters and post-PCI long-term clinical outcomes: From the FU-Registry.来自FU注册研究:胆固醇相关参数目标水平与PCI术后长期临床结局的性别差异
J Cardiol. 2018 Mar;71(3):259-267. doi: 10.1016/j.jjcc.2017.09.011. Epub 2017 Nov 10.
4
Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention.经皮冠状动脉介入治疗后C反应蛋白和血脂水平对冠状动脉病变的不同影响。
Coron Artery Dis. 2012 May;23(3):181-7. doi: 10.1097/MCA.0b013e3283519f44.
5
Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.低密度脂蛋白胆固醇低于70mg/dL的患者在择期经皮冠状动脉介入治疗后高密度脂蛋白胆固醇与围手术期心肌损伤的关系
J Am Heart Assoc. 2015 Jan 8;4(1):e001412. doi: 10.1161/JAHA.114.001412.
6
Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol.低高密度脂蛋白胆固醇是低密度脂蛋白胆固醇得到最佳控制的稳定冠状动脉疾病糖尿病患者长期临床结局的一个残余危险因素。
Heart Vessels. 2014 Jan;29(1):35-41. doi: 10.1007/s00380-013-0330-5. Epub 2013 Mar 21.
7
Impact of Combined C-Reactive Protein and High-Density Lipoprotein Cholesterol Levels on Long-Term Outcomes in Patients With Coronary Artery Disease After a First Percutaneous Coronary Intervention.首次经皮冠状动脉介入治疗后,C反应蛋白与高密度脂蛋白胆固醇联合水平对冠心病患者长期预后的影响
Am J Cardiol. 2015 Oct 1;116(7):999-1002. doi: 10.1016/j.amjcard.2015.06.036. Epub 2015 Jul 15.
8
[Different effects of inflammation and lipid levels on coronary lesions after PCI].[炎症和血脂水平对经皮冠状动脉介入治疗后冠状动脉病变的不同影响]
Zhonghua Yi Xue Za Zhi. 2009 Aug 25;89(32):2249-52.
9
Impact of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio on long-term outcome in patients undergoing percutaneous coronary intervention.载脂蛋白 B/载脂蛋白 A1 比值对经皮冠状动脉介入治疗患者长期预后的影响。
Circ J. 2011;75(4):905-10. doi: 10.1253/circj.cj-10-0258. Epub 2011 Feb 11.
10
The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.他汀类药物治疗期间提高高密度脂蛋白胆固醇的有益效果取决于低密度脂蛋白胆固醇所达到的水平:对冠状动脉粥样硬化进展和心血管事件的影响。
Eur J Prev Cardiol. 2016 Mar;23(5):474-85. doi: 10.1177/2047487315572920. Epub 2015 Feb 17.

引用本文的文献

1
Coping strategies and changes in type D personality were associated with depressive tendency at 9 months after percutaneous coronary intervention.应对策略和D型人格的变化与经皮冠状动脉介入治疗9个月后的抑郁倾向相关。
PLoS One. 2025 Jan 13;20(1):e0316639. doi: 10.1371/journal.pone.0316639. eCollection 2025.
2
The Association of Depression with Type D Personality and Coping Strategies in Patients with Coronary Artery Disease.冠心病患者中抑郁症与D型人格及应对策略的关联
Intern Med. 2020;59(13):1589-1595. doi: 10.2169/internalmedicine.3803-19. Epub 2020 Jul 1.
3
Association of LDL-C/HDL-C Ratio With Stroke Outcomes Within 1 Year After Onset: A Hospital-Based Follow-Up Study.
低密度脂蛋白胆固醇/高密度脂蛋白胆固醇比值与发病后1年内卒中结局的关联:一项基于医院的随访研究
Front Neurol. 2020 May 15;11:408. doi: 10.3389/fneur.2020.00408. eCollection 2020.
4
Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.评估 LDL-C/HDL-C 比值对经皮冠状动脉介入治疗和药物洗脱支架置入术后急性冠脉综合征患者一年临床结局的预测价值。
Lipids Health Dis. 2019 Feb 2;18(1):40. doi: 10.1186/s12944-019-0979-6.
5
Angiotensin type 1 receptor A1166C gene polymorphism is associated with endothelial dysfunction and in-stent restenosis after percutaneous coronary intervention.血管紧张素1型受体A1166C基因多态性与经皮冠状动脉介入治疗后的内皮功能障碍及支架内再狭窄相关。
Int J Clin Exp Pathol. 2015 Jun 1;8(6):7350-7. eCollection 2015.